Building a Pipeline of Quality Treatment Leads

Treatment Receipt Versus Unmet Need

Marketing plans for treatment centers often open with a demand story: overdose deaths, prevalence estimates, waitlists. The federal data tells a different story about where the constraint actually sits. SAMHSA’s 2024 National Survey on Drug Use and Health found that among people aged 12 or older with a past-year substance use disorder, 12.3%—roughly 5.9 million people—received substance-use treatment, while 87.7%—about 42.4 million—did not ¹. The untreated population is nearly seven times the size of the treated one.

Read carefully, that gap is not a green light to chase volume. It is a diagnostic. If nine out of ten people with a diagnosable disorder do not enter treatment in a given year, the friction points are upstream of ad impressions: stigma, cost perception, insurance confusion, ambivalence about readiness, geographic reach, and lack of a trusted referrer. A pipeline that pushes more undifferentiated inquiries into an admissions queue does not close that gap; it clogs the queue with contacts who will not clinically or financially convert.

The operator implication is to build demand generation that pre-qualifies. Content, ad targeting, and intake scripting should surface level of care, payer, geography, and readiness early, so the treated 12.3% who reach the door are the ones the program can actually serve.

The Facility Landscape and What It Means for Local Content

Supply-side density matters as much as demand. SAMHSA’s 2024 National Substance Use and Mental Health Services Survey counted 21,205 treatment facilities across the country, including 15,953 substance-use facilities, 14,091 mental-health facilities, and 8,839 combined substance-use and mental-health facilities ². A prospective patient in most metros has dozens of accredited options within a reasonable drive, plus telehealth entrants outside the local licensure map.

That density reshapes what a content program should produce. Broad category pages competing on “drug rehab” or “detox near me” put a program into a bidding contest against every other facility in the region, most of which look interchangeable at the SERP level. The more defensible position is narrow: a specific level of care, a specific population, a specific payer posture, a specific clinical modality, in a specific catchment. Facility counts do not measure bed availability, admission windows, or clinical differentiation, which means most competitors have not published the information a matched inquiry needs to self-select.

Local content should encode what a referring clinician would ask: ASAM level of care offered, medications available, co-occurring capacity, licensure jurisdictions, in-network payers, and admission timelines. Pages that answer those questions filter inquiries before the phone rings and reduce wasted admissions cycles.

Five Filters Before an Admissions Coordinator Picks Up

Generic lead scoring—demographics, behavior points, time on page—does not translate into treatment. Admissions coordinators screen against five clinical and operational filters, and a pipeline that ignores any of them will manufacture wasted assessments.

1. Clinical acuity. Withdrawal risk, suicidality, active psychosis, and medical comorbidity determine whether the immediate need is an emergency department, a medically managed detox, or an outpatient assessment. Inquiries that surface acuity language early let the coordinator route rather than triage cold.

2. Level-of-care fit. ASAM criteria distinguish outpatient, intensive outpatient, partial hospitalization, residential, and medically managed inpatient care. A program that admits at 3.5 cannot productively enroll an inquiry seeking a 1.0 telehealth cadence, and the reverse creates undertreatment risk.

3. Geography and licensure. A brick-and-mortar program is bounded by its state licensure, transportation reality, and the referring clinician’s catchment. Telehealth extends reach into licensed states only. Inquiries from outside those boundaries are referrals to make, not admissions to close.

4. Payer eligibility. In-network status, out-of-network benefits, single-case agreement history, Medicaid participation, and self-pay capacity define whether an admission is financially viable. Federal parity rules shape what plans must cover but do not guarantee authorization for any specific service ¹¹.

5. Readiness. Contemplation, family pressure, court mandate, and post-discharge urgency each carry different conversion probabilities and different clinical starting points. Readiness is not a disqualifier; it is a routing variable that changes admission timing and pre-admission engagement.

An inquiry that clears all five is what admissions should be measured against. One that clears four is a referral opportunity or a nurture candidate. One that clears fewer is not a lead.

Where Content Marketing Feeds the Stack

Each filter has a content analog that lets prospects self-sort before they call. Acuity is addressed by clinical explainers on withdrawal, co-occurring conditions, and when to go to an emergency department—content that redirects unsafe inquiries rather than absorbing them. Level-of-care fit is addressed by pages that describe ASAM levels in plain language and name what the program actually offers, with medications and modalities specified.

Geography is addressed by location-specific pages that state licensure jurisdictions, telehealth coverage, and admission logistics rather than generic “serving nationwide” language. Payer content should explain verification of benefits, typical utilization review touchpoints, and out-of-network mechanics honestly; NIAAA guidance to referring clinicians notes that availability and quality vary widely and price is not a proxy for outcome, which is the standard comparison pages should meet ¹⁴. Readiness is addressed by content that speaks to the family member searching at 2 a.m., the professional weighing intensive outpatient against residential, and the person seven days post-discharge from a hospital.

Content built this way does two things at once: it improves discoverability against the density of options a prospect encounters, and it filters the inquiries that reach the admissions queue so the queue can move faster.

Tracking Technologies, Forms, and Call Data

The instrumentation layer that most operators inherited from a general marketing agency is now the largest unmanaged liability on the site. HHS Office for Civil Rights guidance states that when tracking technologies collect information relating to a person’s health care, payment, or past, present, or future health, HIPAA obligations may attach; registration pages and authenticated pages can involve disclosures of protected health information ⁵. On a treatment website, a page titled “opioid detox admissions” combined with an IP address, a click ID, and a form submission is not neutral analytics data.

The FTC’s April 2024 action against Monument made the enforcement risk concrete. The proposed order banned the company from disclosing health information for advertising and required affirmative consent before sharing health information with third parties for other purposes ⁸. That reaches directly into the plumbing most treatment sites still run: Meta Pixel on the VOB form, Google Ads conversion tags firing on the thank-you page, session-replay tools recording chat inputs, and call-tracking numbers passing dynamic parameters to advertising platforms.

The design response is inventory before optimization. Map every tag, pixel, chat widget, call-tracking swap, and CRM connector against the page and event that triggers it, then remove or gate anything that transmits health-adjacent data to a non-BAA vendor.

42 CFR Part 2 in the CRM and Referral Layer

Part 2 sits on top of HIPAA for programs holding records that identify a person as having sought or received SUD services. The 2024 final rule was published in February 2024, became effective April 16, 2024, and required compliance by February 16, 2026, aligning selected provisions with HIPAA while implementing CARES Act changes ⁶. The regulation itself requires programs to inform patients that federal law protects the confidentiality of SUD records and governs consent, redisclosure, and patient access ⁷.

For pipeline operations, the practical surfaces are the CRM, the call recording archive, the email nurture platform, and the referral partner integrations. An inquiry captured in a lead form, tagged with “heroin residential,” and synced to a marketing automation tool has become a Part 2 concern the moment the program touches it. Consent language on the form, redisclosure controls on outbound referrals to alumni programs or sober living, and role-based access inside the CRM are the operational tests. Vendor selection should filter on Part 2 fluency, not only a signed BAA.

Substantiating Claims Under FTC Scrutiny

The content layer carries its own exposure. FTC guidance requires that health-related advertising claims be supported by solid proof and not be false, misleading, or unsupported ¹⁰. The January 2025 FTC lawsuit against Evoke Wellness and its executives alleged that the company misled consumers seeking SUD treatment, a signal that enforcement attention on the sector has continued past the earlier privacy cases ⁹.

The claims that create the most risk are the ones marketing teams reach for by default:

• Success rates without a defined denominator
• “Industry-leading” or “most effective” comparatives
• Guarantees of sobriety or completion
• Outcome statistics lifted from a single internal cohort and presented as program-wide
• Implying a program provides services it does not directly deliver, or obscuring the actual operating entity, location, and licensure behind a national-sounding brand

The defensible standard is narrower and more useful. Publish what can be substantiated: ASAM level of care, medications offered, clinical credentials, accreditations, licensure jurisdictions, in-network payers, and program-specific processes. Where outcomes appear, name the cohort, the measurement window, the definition, and the source. Removing an unsupported headline claim rarely costs conversions; carrying it costs cases.

The KPI Hierarchy That Actually Predicts Census

Cost per lead is a top-of-funnel accounting artifact. It tells the media buyer whether the auction is behaving and tells the admissions director almost nothing. A pipeline built around the definition established earlier—an attended clinical assessment with a documented level-of-care recommendation—needs a KPI stack that ends at census and revenue, not at form submissions.

A workable hierarchy runs in five layers:

1. Inquiry volume and inquiry cost sit at the top as diagnostic signals for channel health.
2. Qualified inquiry rate—the share clearing the acuity, level-of-care, geography, payer, and readiness filters—measures whether the top of the funnel is matched to the program.
3. Attended-assessment rate measures whether admissions operations convert qualified interest into a clinical event.
4. Admission rate from assessment measures clinical and financial fit at the point of decision.
5. Completed episode rate, mirroring the initiation-and-engagement construct CMS uses to measure marketplace enrollee treatment for alcohol and other drug use disorder ⁴, measures whether the census the pipeline produced actually stays long enough to generate outcomes and revenue.

Cost per quality admission divides total acquisition spend—media, content, agency, admissions labor allocated to inquiry handling—by admissions produced. That single number reconciles marketing and operations against the same denominator.

A Cost-per-Quality-Admission Worksheet

The worksheet below uses variables rather than invented benchmarks. Operators should populate each cell from their own CRM, call-tracking, and admissions data for a defined window—typically a rolling 90 days—and rerun quarterly.

Two sourced benchmarks anchor the interpretation. The rapid-access randomized trial in an addiction-medicine referral setting reported that 85% of the rapid-intervention group attended at least one appointment within six months, versus 29% of the delayed group ³. That is the ceiling and floor a program’s qualification-to-assessment conversion should be read against, with the caveat that the trial studied referral to addiction-medicine clinics, not residential admissions. CMS’s finding that marketplace initiation and engagement rose from 21.4% to 23.7% between 2016 and 2018 ⁴ frames what plan-population treatment completion looks like at scale and gives the completed-episode row a reality check.

If You Manage Multiple Facilities or Levels of Care

The scope shifts here. Single-site operators can run one worksheet; multi-facility portfolios and programs offering multiple levels of care cannot aggregate without distorting the number they need to manage.

Payer mix differs by facility. Licensure differs by state. ASAM level of care carries its own conversion curve—residential admissions run a slower assessment-to-admission cycle than intensive outpatient, and cost per quality admission at a medically managed detox rarely resembles the same figure at an outpatient program. Rolling those into a portfolio average produces a headline that no facility director can act on.

The operating discipline is to run the worksheet per facility and per level of care, then aggregate only for board-level reporting. Channel attribution should be split the same way, because a paid campaign that performs at one location’s payer mix and admission window may underperform at another with different in-network status or licensure reach. Where a facility’s qualified-inquiry rate drops sharply below the portfolio, the diagnosis usually sits in content-market fit or intake routing, not media price.